8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)-
- CAS No.
- 1352090-52-8
- Chemical Name:
- 8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)-
- Synonyms
- NC9;NC9 TG2 inhibitor;NC-9 TG2 inhibitor;N-alpha-Carbobenzyloxy-N-epsilon-acryloyl-L-lysine(2-(2-dansylaminoethoxy)ethoxy)ethanamide;8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)-
- CBNumber:
- CB98645756
- Molecular Formula:
- C35H47N5O8S
- Molecular Weight:
- 697.84
- MDL Number:
- MOL File:
- 1352090-52-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | CEC09052 | NC9 | 1352090-52-8 | 25mg | $1164.25 | 2026-06-04 | Buy |
| Biosynth | CEC09052 | NC9 | 1352090-52-8 | 50mg | $1620 | 2026-06-04 | Buy |
| ChemScene | CS-0103723 | NC9 99.98% | 1352090-52-8 | 5mg | $227 | 2026-06-04 | Buy |
| ChemScene | CS-0103723 | NC9 99.98% | 1352090-52-8 | 10mg | $368 | 2026-06-04 | Buy |
| ChemScene | CS-0103723 | NC9 99.98% | 1352090-52-8 | 25mg | $737 | 2026-06-04 | Buy |
8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)- Chemical Properties, Uses, Production
Description
NC9 is a irreversible transglutaminase 2 (TG2) inhibitor. NC9 also inhibits Factor XIIIA (FXIIIA).
Uses
NC9 (Cbz-Lys(Acr)-PEG2-dansyl) is an irreversible transglutaminase (TG) inhibitor. NC9 inhibits osteoblast differentiation and mineralization. NC9 destabilizes microtubules. NC9 can be used for the research of osteoblast differentiation[1].
References
[1] Al-Jallad HF, et al. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. PLoS One. 2011 Jan 20;6(1):e15893. DOI:10.1371/journal.pone.0015893
8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)- Preparation Products And Raw materials
Raw materials
Preparation Products
8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Beckham Medical Technology Co., Ltd | 13816613772 | huahero21@sina.com | China | 2994 | 55 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9799 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Guangzhou Ruidi Biotechnology Co., Ltd. | 020-82099279 18988941402 | sales@ubiochem.com | China | 9998 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
View Latest Price from 8,11-Dioxa-2,5-diazatridecanoic acid, 13-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-4-oxo-3-[4-[(1-oxo-2-propen-1-yl)amino]butyl]-, phenylmethyl ester, (3S)- manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-15 | NC9 TG2 inhibitor
1352090-52-8
|
$1520.00-2500.00 | 10g | TargetMol Chemicals Inc. |
-

- NC9 TG2 inhibitor
1352090-52-8
- $1520.00-2500.00
- TargetMol Chemicals Inc.




